Valamehr Bahram
SEC insider (Form 3/4/5 filer). CIK 0001748177. President and CEO at FATE THERAPEUTICS INC (FATE). 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 4, 2026. Located in SAN DIEGO, CA.
Companies Valamehr Bahram has filed insider reports for
- FATE THERAPEUTICS INC (FATE): Director, Officer, President and CEO
Valamehr Bahram
CIK: 0001748177
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FATE THERAPEUTICS INC
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Aug 4, 2026FATE
FATE THERAPEUTICS INC
SaleDirect43.9K shares at avg. $2.46$108K - May 20, 2026FATE
FATE THERAPEUTICS INC
SaleDirect28.9K shares at avg. $1.88$54K - Jan 15, 2026FATE
FATE THERAPEUTICS INC
AwardDirect335K shares- - Jan 9, 2026FATE
FATE THERAPEUTICS INC
SaleDirect5.2K shares at avg. $1.07$6K - Aug 4, 2025FATE
FATE THERAPEUTICS INC
SaleDirect14.5K shares at avg. $1.06$15K - Jan 16, 2025FATE
FATE THERAPEUTICS INC
AwardDirectStock Option (Right to Buy)
1.3M shares- - Jan 10, 2025FATE
FATE THERAPEUTICS INC
SaleDirect8.7K shares at avg. $1.54$13K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 4, 2026 | FATE FATE THERAPEUTICS INC | Sale | 43,947 | $2.46 | $108,101 | Direct |
| May 20, 2026 | FATE FATE THERAPEUTICS INC | Sale | 28,946 | $1.88 | $54,482 | Direct |
| Jan 15, 2026 | FATE FATE THERAPEUTICS INC | Award | 335,000 | - | $0 | Direct |
| Jan 9, 2026 | FATE FATE THERAPEUTICS INC | Sale | 5,190 | $1.07 | $5,557 | Direct |
| Aug 4, 2025 | FATE FATE THERAPEUTICS INC | Sale | 14,466 | $1.06 | $15,396 | Direct |
| Jan 16, 2025 | FATE FATE THERAPEUTICS INC | Award Stock Option (Right to Buy) | 1,300,000 | - | - | Direct |
| Jan 10, 2025 | FATE FATE THERAPEUTICS INC | Sale | 8,705 | $1.54 | $13,406 | Direct |
1-7 of 7 transactions